Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

FTO-IN-1 TFA

Inquiry
Cat. No.: OB0425LY-121
Synonyms: 2797619-81-7; 2-[2,6-Dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)anilino]-N-hydroxybenzamide;2,2,2-trifluoroacetic acid
Size: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg; 500 mg
CAS No.: 2797619-81-7
Compound CID: 162642722
FTO-IN-1 TFA

Specification

Description: FTO-IN-1 TFA is a novel small molecule inhibitor targeting FTO in the regulation of fat mass and metabolism.
Formula Weight: 505.27
Applications: FTO-IN-1 TFA can be used to study the mechanisms of obesity and metabolic-related diseases, as well as to develop new therapies for obesity and related metabolic disorders.
Storage: Storage at 4°C.
Formula: C20H17Cl2F3N4O4
Appearance: Solid
Purity: 98.06%, determined by LC-MS.
Solubility: DMSO
Pathway: Metabolic enzyme/Protease
Identity: Confirmed by LC-MS.
Target: Fat mass and obesity-associated protein (FTO)

Library Information

Solubility: DMSO
Inquiry

Copyright © Protheragen. All rights reserves.